It’s just frustrating that you go to a GP and you have faith in them, but you don’t get taken seriously,” said Gemma Doherty ...

Did our AI summary help? Cervical cancer was a disease often thought of as something that only affected women in their sixties. But today, cervical cancer is creeping into a much younger demographic.

Oklahoma Children's Hospital is pioneering a targeted chemotherapy treatment for retinoblastoma, a rare eye cancer in children, marking a significant advancement in pediatric cancer care.

The data was shared by the faculty of Post Graduate Institute of Medical Education and Research (PGIMER) as it held an awareness session on women health to celebrate the International Women’s Day on M ...

Colorectal cancer is the deadliest cancer in people under 50 and the second deadliest overall in the United States.

The American Cancer Society predicts that 55,000 people or more will pass away from colorectal cancer this year, and doctors at United Hospital Center (UHC) in Bridgeport are raising awareness for ...

John Tesh reveals how wife Connie Sellecca saved his life during prostate cancer battle. The former TV host credits faith and ...

"Patients do not want to be shielded from difficult treatment decisions," says Associate Professor Jannicke Rabben at Norway's University of Agder (UiA). "Even patients who say that the doctor knows ...

Cancer treatment in India costs 3x more than average ailments. These duty cuts on medicines help reduce out-of-pocket costs in public and private hospitals.

Cancer Clinician and Translational Scientist Dr. Daniela Matei will become the next director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center following a national search, Houston Methodist ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

John Tesh says he has outlived a terminal cancer prognosis by nearly eight years while continuing treatment for metastatic prostate cancer.